Eli Lilly

Company Information from ICIS

Eli Lilly is a major pharmaceutical corporation which develops, manufactures and markets pharmaceutical products. The company has major R&D facilities in seven countries and manufacturing facilities in 13 countries.

Eli Lilly will focus on its ‘innovation-driven’ strategy and invest in R&D with the goal of delivering a steady flow of innovative products. The company will also build the capabilities to manufacture these products and market them effectively around the world, and augment its own capabilities and resources through partnerships.

Eli Lilly is readying a generation of molecules for the market and restocking its early-stage pipeline. Its strength in developing both small-molecule and large-molecule ‘biotech’ medicines is said to distinguish Eli Lilly from most other major pharmaceutical companies.

Download the The ICIS Top 100 Chemical Companies listing here

Key Personnel

Chairman: John Lechleiter
Member: Michael Cook
Member: Michael Eskew
Member: Martin Feldstein
Member: George Fisher
Member: Erik Fyrwald
Member: Alfred Gilman
Member: Karen Horn
Member: Ellen Marram
Member: Franklyn Prendergast
Member: Kathi Seifert


Eli Lilly & Company
Lilly Corporate Centre
PO Box 88665
Indianapolis, Indiana 46285

Tel: +1 317 276 2000
Fax: +1 317 277 6139

Website: www.lilly.com 

ICIS Top 100 Chemical Companies


The ICIS Top 100 Chemical Companies 2015 listing highlights the top players in the global chemical industry.

Most chemical companies found it difficult to generate top line and profit growth in 2015 following a strong performance in 2014. 

ICIS Top 100 Chemical Distributors 2015

ICIS Top 100 Chemical Distributors 2014

ICIS is proud to present the ICIS Top 100 Chemical Distributors. This feature, now in its fifth year is published annually in ICIS Chemical Business, the weekly magazine for the global chemical industry.